Altasciences

Altasciences describes itself as a forward-thinking, mid-size early phase contract research organization in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development, including preclinical safety testing, clinical pharmacology (Phase I to Phase II), bioanalysis (preclinical to Phase IV), research services, and manufacturing and analytical services. It states that for over 30 years it has partnered with sponsors to support educated, faster, and more complete early drug development decisions, and that its integrated, full-service solutions include preclinical safety testing, clinical pharmacology and proof of concept, bioanalysis, manufacturing, program management, medical writing, biostatistics, clinical monitoring, and data management. Its Acceleration Platform replaces traditional sequential development with coordinated execution from a single drug development organization, and it states this can reduce timelines by up to 40%. It operates preclinical, bioanalytical, and clinical facilities across nine locations in North America, including Seattle, Scranton, Kansas City, and Greater Montréal.

Altasciences states that for over 30 years it has been partnering with sponsors to help support educated, faster, and more complete early drug development decisions. It describes its approach as replacing traditional sequential development with coordinated execution from a single drug development organization, integrating nonclinical research, clinical research, bioanalysis, formulation development, manufacturing, and regulatory support within a coordinated development strategy. The company operates preclinical, bioanalytical, and clinical facilities across nine locations in North America, including Seattle, Scranton, Kansas City, and Greater Montréal.

A forward-thinking, mid-size early phase contract research organization in Canada and the U.S., offering a proven, flexible approach to early drug development with a personal touch.

• 2021-05-05

  Altasciences completes acquisition of Calvert Laboratories[5]Altasciences完成对Calvert Laboratories的收购finanznachrichten.de

  Reported: 2021-05-05

  Altasciences completed its acquisition of Calvert Laboratories, a preclinical CRO on the U.S. East Coast. The acquisition adds capabilities and expands Altasciences' East Coast presence.

• 2021-02-12

  Altasciences completes acquisition of WCCT Global[6]Altasciences 完成对 WCCT Global 的收购finanznachrichten.de

  Reported: 2021-02-19

  Altasciences acquired WCCT Global, an early-stage clinical research organization in Southern California. The transaction was completed on February 12.

1. 1Altasciences - Contract Research Organization | Drug Development | Outsourcing Servicesaltasciences.com
2. 2About Us | Integrated Mid-Size CRO CDMO| Altasciencesaltasciences.com
3. 3Bioanalytical Services | Altasciencesaltasciences.com
4. 4Home - Altasciencesaltasciences.com
5. 5Altasciences完成对Calvert Laboratories的收购finanznachrichten.de
6. 6Altasciences 完成对 WCCT Global 的收购finanznachrichten.de